Balogh Mihály
Balogh Mihály
Pharm.D., Ph.D.; MD Anderson Cancer Center
E-mail megerősítve itt:
Hivatkozott rá
Hivatkozott rá
Effects of articaine on [3H] noradrenaline release from cortical and spinal cord slices prepared from normal and streptozotocin-induced diabetic rats and compared to lidocaine
D Végh, A Somogyi, D Bányai, M Lakatos, M Balogh, M Al-Khrasani, ...
Brain Research Bulletin 135, 157-162, 2017
New morphine analogs produce peripheral antinociception within a certain dose range of their systemic administration
E Lackó, P Riba, Z Giricz, A Váradi, L Cornic, M Balogh, K Király, K Csekő, ...
Journal of Pharmacology and Experimental Therapeutics 359 (1), 171-181, 2016
The peripheral versus central antinociception of a novel opioid agonist: acute inflammatory pain in rats
M Balogh, ZS Zádori, B Lázár, D Karádi, S László, SA Mousa, S Hosztafi, ...
Neurochemical research 43 (6), 1250-1257, 2018
A new potent analgesic agent with reduced liability to produce morphine tolerance
K Kiraly, FF Caputi, A Hanuska, E Kató, M Balogh, L Köles, M Palmisano, ...
Brain Research Bulletin 117, 32-38, 2015
New opioid receptor antagonist: Naltrexone-14-O-sulfate synthesis and pharmacology
AKM Zádor F, Király K, Váradi A, Balogh M, Fehér Á, Kocsis D, Erdei AI ...
European Journal of Pharmacology, 2017
Efficacy-based perspective to overcome reduced opioid analgesia of advanced painful diabetic neuropathy in rats
M Balogh, F Zádor, ZS Zádori, M Shaqura, K Király, A Mohammadzadeh, ...
Frontiers in pharmacology 10, 347, 2019
14-O-Methylmorphine: a novel selective mu-opioid receptor agonist with high efficacy and affinity
F Zádor, M Balogh, A Váradi, ZS Zádori, K Király, E Szűcs, B Varga, ...
European Journal of Pharmacology 814, 264-273, 2017
Glycine transporter inhibitors: A new avenue for managing neuropathic pain
M Al-Khrasani, A Mohammadzadeh, M Balogh, K Király, S Barsi, B Hajnal, ...
Brain research bulletin 152, 143-158, 2019
Analysing the effect of I1 imidazoline receptor ligands on DSS-induced acute colitis in mice
Á Fehér, VE Tóth, M Al-Khrasani, M Balogh, B Lázár, Z Helyes, K Gyires, ...
Inflammopharmacology 25 (1), 107-118, 2017
Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate
F Zádor, A Mohammadzadeh, M Balogh, ZS Zádori, K Király, S Barsi, ...
Molecules 25 (6), 1370, 2020
Similarity and dissimilarity in antinociceptive effects of dipeptidyl-peptidase 4 inhibitors, Diprotin A and vildagliptin in rat inflammatory pain models following spinal …
M Balogh, BK Varga, DÁ Karádi, P Riba, Z Puskár, M Kozsurek, ...
Brain research bulletin 147, 78-85, 2019
Lack of Small Intestinal Dysbiosis Following Long-Term Selective Inhibition of Cyclooxygenase-2 by Rofecoxib in the Rat
B Lázár, GB Brenner, A Makkos, M Balogh, SB László, M Al-Khrasani, ...
Cells 8 (3), 251, 2019
Biochemical and pharmacological characterization of three opioid-nociceptin hybrid peptide ligands reveals substantially differing modes of their actions
AI Erdei, A Borbély, A Magyar, N Taricska, A Perczel, O Zsíros, G Garab, ...
Peptides 99, 205-216, 2018
Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats
SB László, B Lázár, GB Brenner, A Makkos, M Balogh, M Al-Khrasani, ...
Biochemical Pharmacology, 114099, 2020
On the Role of Peripheral Sensory and Gut Mu Opioid Receptors: Peripheral Analgesia and Tolerance
S Fürst, ZS Zádori, F Zádor, K Király, M Balogh, SB László, B Hutka, ...
Molecules 25 (11), 2473, 2020
Peripheral and central analgesic components of a novel opioid in the management of inflammatory and neuropathic pain
M Balogh
Semmelweis University, 2019
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–16